state intermediate 15 , and an aspartate side chain may suppress the pK a of lysine on a substrate 16 . These findings have led to the proposal that RING E3 binding may organize the E2's active site through allosteric effects to enhance substrate ubiquitination 8, 9 .
Donor ub-ubcH5b interactions Our structure shows detailed molecular interactions between a donor Ub covalently linked to an E2 in the presence of a RING E3. Unlike other published E2~Ub structures, our E2~Ub conjugate appears poised for transfer. The Ile44 patch of Ub makes extensive noncovalent interactions with the entire length of UbcH5B's a3 (Fig. 2a) . Recently, E2's a3-Ub Ile44 surface interactions have been identified to be important for Ub transfer by the E2s Ube2S and Cdc34 (refs. 9,10); for Cdc34, an S129L mutation on a3 of the E2, combined with an I44A mutation on Ub, rescues Ub transfer defects associated with the individual mutants. In our structure, Ser108 of UbcH5B (corresponding to Ser129 in Cdc34) interacts with Ile44 of Ub. To assess the importance of the observed interactions, we performed in vitro single-turnover lysine discharge 4 , autoubiquitination and SMAC ubiquitination assays under pulse-chase conditions to eliminate mutational effects from E1-catalyzed UbcH5B~Ub formation (Supplementary Note). Mutations of key residues on UbcH5B's a3 (K101E, L104A, S108R and D112A) and Ub's Ile44 surface (L8D, R42E, I44A, G47E, Q49E and H68A V70A) cause defects in Ub transfer (Fig. 2b,c and Supplementary Fig. 2a-g ). In addition, Ub's L8D and I44A and UbcH5B's S108R greatly reduce binding affinity when incorporated into UbcH5B S~U b ( Table 1) .
The observed UbcH5B~Ub conformation precludes binding of the donor Ub to UbcH5B's backside in the presence of BIRC7, because both interactions use the same Ub surface. To investigate the role of UbcH5B's backside binding, we tested UbcH5B S22R in BIRC7-catalyzed assays. UbcH5B S22R displayed similar activity as wild-type in lysine discharge assays but was strongly defective in polyubiquitinating BIRC7 and SMAC ( Fig. 2b and Supplementary Fig. 2d,e) , including caspases and second mitochondrial activator of caspases (SMAC), for activation of NF-kB signaling and for degradation of other proteins (reviewed in ref. 23 ). To gain insights into the role of RING dimerization and to understand how RING E3s interact with E2~Ub to promote Ub transfer, we used the BIRC RING E3s as a model system and determined the crystal structure of the dimeric BIRC7 (also known as melanoma inhibitor of apoptosis protein and Livin) RING domain in complex with UbcH5B covalently linked to Ub's C terminus. Along with NMR and biochemical analysis, the data reveal that combined interactions between UbcH5B, donor Ub and the BIRC7 RING dimer are crucial for Ub transfer, elucidate the roles of catalytically important residues outside E2's active and RING-binding sites, and identify noncanonical interactions between the Ile36 surface of Ub and the BIRC7 RING dimer. We propose that, as suggested for several RING E3s 8, 9, 18 , BIRC7 promotes activity by stabilizing an optimal E2~donor Ub arrangement for Ub transfer. Here, to our knowledge, we show the first detailed structural evidence supporting this hypothesis. results characterization of the birc7 ring-ubcH5b~ub complex Several homodimeric RING E3s, such as RNF4 and BIRC3, have distinct binding preferences for E2~Ub as compared to E2 (refs. 18,21) . To determine whether BIRC7 has similar preferences, we measured binding affinities of the BIRC7 and BIRC3 RING domains for UbcH5B~Ub and UbcH5B by using surface plasmon resonance (SPR) analysis. Because E2 thioesterified with Ub rapidly dissociates into E2 and Ub in the presence of RING E3, UbcH5B's catalytic Cys85 was mutated to serine to generate a stable covalent ester linkage (UbcH5B S~U b). Like BIRC3, BIRC7 showed a higher binding affinity for UbcH5B S~U b than for UbcH5B ( Table 1 and Supplementary Fig. 1 ), suggesting that the donor Ub contributes to the RING E3-E2~Ub interaction.
To investigate the donor Ub role in binding, we determined the structure of BIRC7 RING domain (BIRC7 239-C ) bound to UbcH5B S S22R N77A~Ub (UbcH5B RAS~U b) to 2.18 Å ( Fig. 1 and Table 2 ). We attempted to crystallize the BIRC7 239-C bound to UbcH5B S~U b but found that it dissociated to UbcH5B and Ub after 1-3 days; hence, we mutated Asn77 within the highly conserved E2 HPN motif 15 to alanine to increase UbcH5B S~U b stability. UbcH5B's Ser22 was mutated to arginine to prevent backside binding with Ub 14 . The complex has a compact overall structure with two copies of the BIRC7 239-C -UbcH5B RAS~U b heterotrimer in the asymmetric unit (r.m.s. deviation of 0.43 Å for Ca atoms). For simplicity, we differentiate molecules from the two heterotrimers with A or B subscripts (for example, BIRC7 A or Ub B ; Fig. 1 ). The structures of UbcH5B RAS and Ub resemble previously published UbcH5B and Ub structures 24 (r.m.s. deviation of 0.43 and 0.42 Å, respectively, for Ca atoms). The structure of BIRC7 239-C is similar to the BIRC3 RING domain 17 (r.m.s. deviation of 1.13 Å for Ca atoms), as an a-helix precedes the RING domain, and the C-terminal tails of BIRC7 from both subunits participate in RING dimerization (Fig. 1) .
The canonical RING-E2 interactions described previously 12, 17 are conserved in our BIRC7 239-C -UbcH5B RAS~U b complex. Ub nestles along UbcH5B's a3 and the BIRC7 RING domain within each subunit of the asymmetric unit. Notably, the C-terminal tail of BIRC7 B packs against Ub A, and the C-terminal tail of BIRC7 A packs against Ub B (Fig. 1) . Ub's Ile44 and Ile36 patches make extensive contacts with UbcH5B and the BIRC7 dimer, respectively. The C-terminal tail of Ub lies along the interface between UbcH5B's a2 and a3, making numerous contacts with UbcH5B, the globular Ub body and the RING domain (Fig. 1) . The quality of the electron density was better for subunit A of the BIRC7 239-C -UbcH5B RAS~U b complex, so we focus on this subunit and the C-terminal tail of BIRC7 B . a r t i c l e s npg suppression during catalysis 16 . Mutation of Asp117 produces defects in Ub transfer mediated by BIRC7 ( Fig. 2b and Supplementary Fig. 2d ,e) and other RING E3s 4, 8, 24 . Notably, UbcH5B S D117A~Ub and UbcH5B S~U b display similar binding affinities for BIRC7 (Table 1) , which suggests that Asp117 may not be involved in E2~Ub recruitment but may instead have an alternative role in catalysis. Whether the observed E2 active site conformation is optimized for transfer or is a product of the N77A mutation requires further investigation.
consistent with previous reports showing that backside binding is required for polyubiquitination 14, 24 .
Residues 71-74 of the C-terminal tail of Ub A are maintained by contacts with UbcH5B A 's a2, Ub A 's Leu8, Leu71 and Leu73, and BIRC7 A 's Arg286 (Fig. 2d,e) . To probe the importance of these interactions, we tested the activity of several Ub tail-interacting mutants: UbcH5B's D87A, I88A and L97A and Ub's L71D and L73D were defective in BIRC7-mediated Ub transfer (Fig. 2b,c and Supplementary Fig. 2d-g ). Furthermore, UbcH5B S I88A~Ub had reduced BIRC7 binding affinity ( Table 1) , which suggested that the conformation of Ub's C-terminal tail residues 71-74 is crucial for Ub transfer.
When compared to other UbcH5~Ub structures (PDB 3A33 and 3UGB) 24, 25 , there is a paucity of interactions between the UbcH5 loop, comprising residues 114-119 (loop 114-119), and residues 75 and 76 of Ub. In these other structures, the side chain of Asp117 interacts with the amide of Ub's Gly76, and loop 114-119 is stabilized by hydrophilic interactions with Asn77. In BIRC7 239-C -UbcH5B RAS~U b, the average B factors for the two tail Ub residues (115 Å 2 ) and loop 114-119 (95.7 Å 2 ) are high compared to that of the overall structure; no electron density is present for several of the loop 114-119 side chains, and electron density for the ester linkage is visible but poor around Ub's Gly75, preventing accurate positioning of the carbonyl group of this residue (Fig. 2e) . Nonetheless, modeling of Asn77 from the UbcH5B S~U b structure (PDB 3A33) 24 onto UbcH5B A 's N77A suggests that the asparagine Nd is within hydrogenbonding distance of Ub A 's Gly76 carbonyl oxygen, although the angles may not reflect transition-state geometries (Supplementary Fig. 2h ).
Previously, mutational analyses have shown that loop 114-119 is crucial in UbcH5-mediated catalysis 4, 8, 24 . Structural alignments of the Ca atoms of UbcH5B RAS~U b with available structures of UbcH5B and UbcH5B~Ub variants show loop 114-119 adopts multiple conformations ( Supplementary Fig. 2i ), which suggests that the loop is flexible. Moreover, superposition of UbcH5B from our structure onto the SUMO E2 Ubc9 in the SUMO-RanGAP1-Ubc9-Nup358 complex structure 26 (r.m.s. deviation of 1.12 Å for Ca atoms, Supplementary Fig. 2j -l) reveals a similar E2-Ub like protein (Ubl) tail conformation. In Ubc9, Asp127 (corresponding to UbcH5B's Asp117) contacts the amino group of lysine on the substrate and has been shown to play a critical part in lysine pK a To probe our BIRC7 A RING-BIRC7 B tailUbcH5B A~U b A arrangement, we hypothesized that a dimer comprising a subunit of BIRC7 with a tail mutation and a second subunit with a RING mutation should be active. For our RING mutation, we generated BIRC7 V254A, which greatly reduces binding affinity for UbcH5B S~U b and is defective in autoubiquitination ( Table 1 and Fig. 3e ). Incubation of a mixture of BIRC7 V254A with BIRC7 F296H led to enhanced autoubiquitination activity (Fig. 3e) . Thus, the cross-dimer BIRC7 A RING-BIRC7 B tail arrangement and ensuing interactions with donor Ub are required for UbcH5B~Ub recruitment and Ub transfer. birc7 binding reorganizes the donor ub conformation Our structural and biochemical data show that BIRC7 promotes Ub transfer by stabilizing UbcH5B and the donor Ub in a conformation optimal for conjugation. To confirm whether the donor Ub forms noncovalent interactions with UbcH5B and BIRC7 in solution, we charged UbcH5B RAS with 15 Fig. 4a and Supplementary Fig. 4a) . As suggested by the shift perturbations and the inability of UbcH5B RAS to backside bind, Ub may interact with UbcH5B's a3 in a similar manner to that observed in Ubc1~Ub and Ube2S~Ub models 10, 27 . Mapping of these perturbations onto Ub A reveals that some perturbations radiate away from the UbcH5B-Ub binding interface (Fig. 4b) , which suggests that Ub Ile44 patch-UbcH5B interactions are preferred, but donor Ub may populate other conformations, as observed in UbcH5C~Ub complexes 14, 28 .
Titration of an increasing molar ratio of BIRC7 239-C to UbcH5B RAS~ [ 15 N]Ub produced gradual chemical-shift perturbations in the spectra (Supplementary Fig. 4b-d) , indicating changes in the donor Ub interaction network. To separate Ub peak-shift perturbations induced by BIRC7 binding from conjugation of Ub to UbcH5B RAS , we compared the peak shifts from the BIRC7 239-C -UbcH5B RAS~ [ 15 N]Ub and the UbcH5B RAS~ [ 15 N]Ub spectra. These perturbations map to regions near the Leu8-Thr9 loop, Ile36 and Ile44 patches and the C-terminal tail residues Leu71 and Leu73 ( Fig. 4c and Supplementary  Fig. 4e ). These regions correspond to the Ub surfaces involved in noncovalent interactions with UbcH5B and BIRC7 in our structure (Fig. 4d) .
Donor ub ile36 patch-birc7 interactions
In Ub A , the Leu8-Thr9 loop and the patch surrounding Ile36 make extensive contacts with the BIRC7 A RING domain and BIRC7 B 's C-terminal tail (Fig. 3a) , providing the first structural evidence, to our knowledge, of donor Ub-RING interactions. Ub A 's Leu8, Thr9, Ile36 and Pro37 form hydrophobic contacts with BIRC7 A 's Ile284 and Zn 2+ -binding ligands, His269 and Cys285. In addition, hydrogen bonds occur between the side chains of BIRC7 A 's Arg286 and Ub A 's Gln40 and between BIRC7 A 's His269 and the backbone oxygen of Ub A 's Gly35. The C-terminal tail of BIRC7 B makes several contacts with Ub A : Arg294 forms a hydrogen bond with the backbone oxygen of Ub A 's Asp32; Phe296 contacts Ub A 's Gly35; and Ser298 sits in a pocket created by Ub A 's Thr9, Lys11 and Glu34.
We generated select mutants to probe the observed Ub-BIRC7 interactions, including a control Ub mutant, D58A, that opposes the Ile44 and Ile36 patches. BIRC7 Phe296 was mutated to histidine because, for the corresponding residue in RNF4, this mutation did not disrupt dimerization but still considerably reduced activity 18 . Ub mutants harboring G35E, I36A or Q40R are defective in BIRC7-mediated Ub transfer, whereas Ub D58A had similar activity to wild-type Ub (Fig. 3b  and Supplementary Fig. 2f,g ). Likewise, BIRC7 I284A, R286A and F296H, which exist as dimers in solution, as shown by size-exclusion chromatography (Supplementary Fig. 3a) , are also defective in catalyzing autoubiquitination (Fig. 3c) . We introduced V263R or a C-terminal tail deletion (D296-298) to disrupt dimerization. These mutants exist as monomers and are inactive in catalyzing BIRC7 autoubiquitination ( Fig. 3c and Supplementary Fig. 3 ). SPR analyses show that UbcH5B S~U b G35E and UbcH5B S~U b I36A have reduced binding affinity for BIRC7, and BIRC7 mutants have reduced binding affinity for UbcH5B S~U b ( Table 1) .
The dimeric arrangement shows that E2~Ub can be recruited by both BIRC7 domains, but competent binding of a single UbcH5B~Ub complex requires both BIRC7 domains-the RING domain of one dimer subunit binds UbcH5B and Ub, whereas the tail of the second dimer supports Ub binding through a cross-dimer arrangement (Fig. 1 Figure 1 , with N atoms blue, O atoms red, and S atoms yellow. Putative hydrogen bonds are shown as dashed lines.
a r t i c l e s npg was used instead of full-length BIRC7. The donor Ub was labeled with [ 32 P]ATP, and we used a histidine-tagged Ub as the acceptor, which cannot be labeled. At our highest achievable UbcH5B~Ub concentration (30 mM), our assay only approached saturation ( Fig. 5a and Supplementary Fig. 5a ) and was thus inappropriate for measuring mutational effects on k cat and K m . Because the BIRC3 RING domain has ~25-fold higher binding affinity for UbcH5B S~U b than does BIRC7 (Table 1) , we hypothesized that it might be suitable for kinetic assays to validate our model. The RING domain of BIRC3 resembles BIRC7 (r.m.s. deviation 1.13 Å), and the sequences are 74% identical (Fig. 5b,c) . In the sequence alignment, the BIRC7 residues that interact with Ub in our structure are identical to those in BIRC3. All of the BIRC7-Ub interactions observed in our structure are present in a model of a BIRC3-UbcH5B~Ub complex built by superposing the RING domain of BIRC3 onto BIRC7 in our complex (Fig. 5d) . Notably, BIRC7 has a valine deletion within a RING These results suggest that donor Ub has a preference to form noncovalent interactions with UbcH5B in the absence of E3, but BIRC7 binding further stabilizes the donor Ub interaction network.
Kinetic validation of the birc-e2~ub model
Our data suggest that disruption of E2-Ub or Ub-E3 interactions are expected to hinder binding of E2~Ub and prevent proper positioning of the donor Ub for transfer-under steady-state conditions, an increase in K m and a decrease in k cat are expected for any mutation that disrupts these interfaces. We attempted to assess mutational effects on k cat and K m by using kinetic analyses on BIRC7-catalyzed diUb formation; to eliminate autoubiquitination, BIRC7 239-C 18 . The RNF4 study demonstrated that dimerization is required for E3 ligase activity and that both subunits of the dimer are crucial for recruiting E2~Ub, as we observed for BIRC7. In the RNF4-E2~Ub model, the Ile44 surface of Ub was predicted to bind to residues at the dimer interface. Instead, Ub's Ile44 surface interacts with E2's a3, and Ub's Ile36 surface contacts the RING dimer interface to position the donor Ub for transfer.
The UbcH5 family also has the ability to bind Ub's Ile44 surface via its backside (Ser22 surface). This ability is crucial for the processivity of polyUb chain synthesis 14, 24 , but the mechanism is unknown. Our results and a recent study on cullin-RING ligases 9 suggest that the donor Ub cannot interact with the backside of any UbcH5 molecule during transfer. Hence, backside binding does not promote polyUb chain formation by positioning the donor Ub for transfer. Although the Ile44 patch on the donor Ub is unavailable during transfer, the backside of the donor UbcH5 (that is, UbcH5~Ub that is bound to E3) is not occupied and may recruit free UbcH5~Ub to enable self-assembly 14, 24, 25 or bind and guide the growing polyUb chain to promote polyUb chain formation 14 . E2s have been shown to collaborate to catalyze polyUb chain formation [29] [30] [31] , so UbcH5 may also recruit other E2~Ub through backside binding. Further studies are required to elucidate the role of backside binding in polyUb formation.
Optimization of noncovalent donor Ub-E2 interactions and positioning of the thioester linkage are mechanisms shared by other types of E3-catalyzed Ub or Ubl transfers. In the NEDD4L-UbcH5B~Ub complex, the HECT E3 NEDD4L binds both UbcH5B and Ub to position the E2~Ub thioester linkage for transfer 32 . The crystal structure of the postconjugated SUMO-RanGAP1-Ubc9-Nup358 complex shows that SUMO E3 Nup358-RanBP2 binds both Ubc9 and SUMO to prevent nonproductive Ubc9~SUMO conformations and to position the Ubc9~SUMO thioester linkage for transfer 26 , though a recent study suggests that Ubc9 has only a structural role in this multisubunit E3 complex 33 . For both E3s, the interactions between E3 and donor Ub or Ubl enhance the catalytic efficiency of the transfer reaction by improving k cat and reducing K m . Our SPR analyses of UbcH5B S~U b variants showed that mutations that disrupt any binding interface increase K d for the BIRC7-UbcH5B~Ub complex. Using BIRC3 541-C , which resembles BIRC7 239-C , we demonstrated that disruption of donor Ub-UbcH5B and donor Ub-RING interactions reduces k cat and increases K m for Ub transfer.
RING E3 binding is proposed to induce allosteric changes in E2's active site to promote Ub transfer 8, 9 . Our data show that conjugation to hydrophobic patch that is involved in E2 binding, which may account for the observed weaker binding affinities ( Fig. 5c and Supplementary  Fig. 5b,c) . To confirm that the BIRC3 and BIRC7 Ub transfer mechanisms are alike, we performed lysine discharge assays using the same sets of mutants tested in the BIRC7 assays. The activity profiles were identical-all of the mutants were defective in Ub transfer except UbcH5B's S22R and Ub's D58A (Fig. 5e and Supplementary Fig. 5d,e) .
We first measured the k cat and K m for diUb formation by using wildtype Ub, UbcH5B and BIRC3 RING domain to determine whether saturating conditions were achievable. Indeed, the K m was well below the highest achievable UbcH5B~Ub concentration (Fig. 5f) . We then selected three mutants for our kinetic assays to validate our model: Ub's I44A and I36A and BIRC3's F602H (corresponding to BIRC7's Phe296). Ub's Ile44 interacts with Ser108 on UbcH5B's a3, and Ub's Ile36 and BIRC3's Phe602 compose part of the E3-Ub interface. Each of these mutants increased K m and decreased k cat , as predicted by our model (Fig. 5g-i and Supplementary Fig. 5f ). Thus, donor Ub interactions with UbcH5B and the RING domain are crucial for optimal Ub transfer.
Discussion
The BIRC7 239-C -UbcH5B RAS~U b structure and biochemical data presented here provide insights into how a RING E3 and dimerization stabilize the donor Ub to facilitate Ub transfer. Our results agree with a previous study on RNF4, in which modeling and biochemical analyses predicted that the RING E3 binds directly to both E2 and the donor Ub, thereby optimizing the E2~Ub conformation and positioning the 
Figure 4, 8 . In our complex, Ub tail residues 71-74 interact with a2 of UbcH5B. BIRC7's Arg286, which is strictly conserved in many RING E3s as arginine or lysine, not only binds UbcH5B's a2 in our structure but also coordinates Ub's tail residues 71-74 to a2 of the E2. The cross-dimer arrangement observed here and in RNF4 (ref. 18 ) is required for donor Ub interactions and E2~Ub recruitment. We find that, when compared to other dimeric RING E3s that function with the UbcH5 family E2s, this dimer arrangement is also observed in the structures of MDM2-MDMX 34 and IDOL 35 but is absent in the structures of BRCA1-BARD1 (ref. 36 ) and RNF2-BMI1 (refs. 19,37) . Modeling of the UbcH5B RAS~U b fragment of our structure onto MDM2-MDMX reveals the presence of a complementary donor Ub-RING interface and a conserved phenylalanine (Phe296 in BIRC7), on the C-terminal tail, required for cross-dimer donor Ub binding (Supplementary Fig. 5g ). In contrast, a similar model of RNF2-BMI1 reveals potential side chain clashes and the absence of favorable cross-dimer donor Ub interactions (Supplementary Fig. 5h) . Indeed, our data ( Table 1 ) and previous studies 18, 21 show that the BIRCs, MDM2-MDMX and RNF4 have binding preferences for E2~Ub rather than for free E2, whereas RNF2-BMI1 has no preference. Clearly, not all dimeric RING E3s recruit E2~Ub in a similar fashion, but our results suggest that RING E3s that adopt conformations similar to the BIRC7 RING dimer may have similar mechanisms of E2~Ub recruitment and Ub transfer.
This mechanism may not be unique to dimeric RING E3s. U-box domains structurally resemble RING domains, and some form active homodimers in a manner analogous to RING E3 dimerization. The structure of PRP19 U-box dimer shows a similar U-box C-terminal tail configuration to BIRC7 but with variations in the C-terminal tail sequence 38 . Modeling of the UbcH5B RAS~U b portion of our structure onto the PRP19 U-box structure reveals a complementary interface between donor Ub and U-box, with slight differences in the mode of C-terminal tail interactions (Supplementary Fig. 5i ), which suggests a similar E2~Ub recruitment mechanism. Interestingly, several monomeric RING domains also exhibit higher binding affinities for E2~Ub than E2, despite lacking the crossdimer arrangement. Examples include cullin-RING ligases 39 , E3a (ref. 40) and c-CBL 41 . Common UbcH5B surface residues outside the E2's active site and E3 binding site, for example Ile88, are essential for Ub transfer mediated by Apc2-Apc11 and CNOT4 (ref. 8). We speculate, on the basis of these observations, that other RING E3s may use similar modes of E2~Ub recruitment and Ub transfer. Finally, our results are supported by recent structural findings on the RNF4 RING-UbcH5A~Ub complex 42 . metHoDs Methods and any associated references are available in the online version of the paper.
Accession codes. Protein Data Bank: Coordinates and structure factors have been deposited with accession code 4AUQ.
Note: Supplementary information is available in the online version of the paper.
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